Page last updated: 2024-08-23

pregnanolone and Brain Diseases

pregnanolone has been researched along with Brain Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elmér, E; Hansson, MJ; Hasegawa, E; Kasuya, K; Månsson, R; Morota, S; Omi, A; Shimazu, M; Uchino, H; Yanagi, S	1
Brown, RC; Han, Z; Lecanu, L; Papadopoulos, V; Yao, ZX	1
Bishnoi, M; Chopra, K; Kulkarni, SK	1

Reviews

1 review(s) available for pregnanolone and Brain Diseases

Article	Year
Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience, 2006, Volume: 138, Issue:3 Topics: Alzheimer Disease; Animals; Brain; Brain Diseases; Glioma; Humans; Models, Neurological; Nervous System Diseases; Peripheral Nervous System; Pregnanolone; Receptors, GABA-A; Steroids	2006

Other Studies

2 other study(ies) available for pregnanolone and Brain Diseases

Article	Year
Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders--specificity vs. toxicity. Experimental neurology, 2009, Volume: 218, Issue:2 Topics: Amino Acid Isomerases; Animals; Boron Compounds; Brain; Brain Diseases; Calcium; Cyclophilins; Dose-Response Relationship, Drug; Humans; Male; Mitochondria; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptidyl-Prolyl Isomerase F; Pregnanolone; Progesterone; Propofol; Rats; Rats, Wistar; Tamoxifen; Trifluoperazine; Trimetazidine	2009
Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Animals; Antipsychotic Agents; Brain Diseases; Control Groups; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Haloperidol; Male; Movement Disorders; Neuroprotective Agents; Oxidative Stress; Pregnanolone; Progesterone; Rats; Rats, Inbred ACI; Receptors, GABA-A	2008

Article

Year

Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders--specificity vs. toxicity.

Experimental neurology, 2009, Volume: 218, Issue:2

Topics: Amino Acid Isomerases; Animals; Boron Compounds; Brain; Brain Diseases; Calcium; Cyclophilins; Dose-Response Relationship, Drug; Humans; Male; Mitochondria; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptidyl-Prolyl Isomerase F; Pregnanolone; Progesterone; Propofol; Rats; Rats, Wistar; Tamoxifen; Trifluoperazine; Trimetazidine

2009

Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.

Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2

Topics: Animals; Antipsychotic Agents; Brain Diseases; Control Groups; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Haloperidol; Male; Movement Disorders; Neuroprotective Agents; Oxidative Stress; Pregnanolone; Progesterone; Rats; Rats, Inbred ACI; Receptors, GABA-A

2008